 |
|
Impact of the COVID-19 Pandemic on Adherence to Denosumab Therapy: A Single Center Study
Kazuyoshi Kobayashi, Koji Sato, Toshihiro Ando, Kei Ando, Saori Imura
Asian Spine J. 2023;17(5):842-850. Published online 2023 Jul 6 DOI: https://doi.org/10.31616/asj.2022.0417
|
|
Citations to this article as recorded by
 Increased risk of depression and anxiety in patients with chronic back pain following COVID-19 infection based on a nationwide population-based study
Joonoh Seo, Namhoo Kim, Kyung-Soo Suk, Byung Ho Lee, Yoonjong Bae, Minae Park, Hyung Joon Ahn, Si-Young Park, Hak-Sun Kim, Seoung-Hwan Moon, Jae-Won Shin, Ji-Won Kwon
Scientific Reports.2025;[Epub] CrossRef Satisfaction Survey of Medical Staff for Telemedicine after the COVID-19 Pandemic: A Comparison Between the COVID-Pandemic and Post-COVID Pandemic Periods
Seung Eun Jung, Young-Mi Kwon, Soon-Yong Kwon, Young-Hoon Kim, Hyung-Youl Park
Telemedicine and e-Health.2024;[Epub] CrossRef The Effect of Subcutaneous Teriparatide Treatment on Mobility, Back Pain, and Patient Satisfaction in Patients with Vertebral Osteoporotic Fractures: A Cross-Sectional Study with 36-Month Follow-up
Ramazan Yilmaz, Sinan Bagcaci
Medical Bulletin of Haseki.2023; 61(4): 260. CrossRef
|